Medilux Laboratories

<h2>Welcome To Medilux Laboratories</h2>

Medilux Laboratories Private Limited is a pharmaceutical chemicals company and CRDMO partner specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates and specialty chemicals. Founded in 1986 and commencing production in 1991, Medilux has developed integrated capabilities spanning process chemistry, research and development, analytical development, technology transfer, scale-up, commercial manufacturing, quality assurance and control, regulatory affairs, supply chain management, project management and intellectual property support. The company serves pharmaceutical innovators and biotechnology companies across international markets.

Medilux operates an integrated manufacturing and R&D facility in Pithampur, Madhya Pradesh. Its 40,000 sq. ft. R&D Centre of Excellence is supported by more than 100 scientists and PhDs and covers 43+ chemistry types. The manufacturing facility comprises seven blocks, including five API blocks and two intermediate blocks, with production capabilities ranging from 0.5 kg to 2 metric tonnes for development and scale-up activities. The company states that its manufacturing operations are accredited or audited against USFDA, EU-GMP, PMDA, WHO-GMP, ISO and EcoVadis requirements.

<div class=”col-md-12 col-sm-12 profile”>
<h3>Company Factsheet</h3>
<table class=”table table-bordered company-factsheet”>
<tbody>

<tr>
<th colspan=”2″>Basic Information</th>
</tr>

<tr>
<td><strong>Nature of Business</strong></td>
<td>Pharmaceutical API, Intermediate &amp; Specialty Chemical Manufacturer / CRDMO</td>
</tr>

<tr>
<td><strong>Additional Business</strong></td>
<td>
<ul>
<li>API Manufacturer</li>
<li>Pharmaceutical Intermediate Manufacturer</li>
<li>Specialty Chemical Manufacturer</li>
<li>Contract Research &amp; Development Organization</li>
<li>Contract Manufacturing</li>
<li>Exporter</li>
<li>Research &amp; Development Service Provider</li>
<li>Technology Transfer &amp; Scale-Up Service Provider</li>
</ul>
</td>
</tr>

<tr>
<td><strong>Company Name</strong></td>
<td>Medilux Laboratories Private Limited</td>
</tr>

<tr>
<td><strong>Managing Director</strong></td>
<td>Deepak K Kewalramani</td>
</tr>

<tr>
<td><strong>Executive Director</strong></td>
<td>Sunjay Kewalrramani</td>
</tr>

<tr>
<td><strong>Year of Establishment</strong></td>
<td>1986</td>
</tr>

<tr>
<td><strong>Year of Commercial Production</strong></td>
<td>1991</td>
</tr>

<tr>
<td><strong>Plant Address</strong></td>
<td>Plot No. 98-99, Sector-1, Industrial Area, Pithampur – 454775, District Dhar, Madhya Pradesh, India</td>
</tr>

<tr>
<td><strong>R&amp;D Centre</strong></td>
<td>Plot No. 22, Sector-1, Industrial Area, Pithampur – 454775, District Dhar, Madhya Pradesh, India</td>
</tr>

<tr>
<td><strong>Industry</strong></td>
<td>Pharmaceutical APIs, Intermediates, Specialty Chemicals, Contract Research, Development and Manufacturing</td>
</tr>

<tr>
<td><strong>Specialization</strong></td>
<td>API Manufacturing, Pharmaceutical Intermediates, Specialty Chemicals, Process Chemistry, R&amp;D, Analytical Development, Scale-Up and CRDMO Services</td>
</tr>

<tr>
<td><strong>Product Categories</strong></td>
<td>
<ul>
<li>Commercial APIs</li>
<li>Under Development APIs</li>
<li>Commercial Pharmaceutical Intermediates</li>
<li>Under Development Intermediates</li>
<li>Specialty Chemicals</li>
</ul>
</td>
</tr>

<tr>
<td><strong>Commercial APIs</strong></td>
<td>20 Commercial APIs</td>
</tr>

<tr>
<td><strong>Under Development APIs</strong></td>
<td>55 Under Development APIs</td>
</tr>

<tr>
<td><strong>Commercial Intermediates</strong></td>
<td>186 Commercial Intermediates</td>
</tr>

<tr>
<td><strong>Under Development Intermediates</strong></td>
<td>74 Under Development Intermediates</td>
</tr>

<tr>
<td><strong>API Examples</strong></td>
<td>
<ul>
<li>Baclofen</li>
<li>Bromfenac Sodium Hydrate</li>
<li>Buspirone Hydrochloride</li>
<li>Bumetanide</li>
<li>Dapsone</li>
<li>Deferasirox</li>
<li>Etomidate</li>
<li>Glimepiride</li>
<li>Hydroquinone</li>
<li>Inosine Pranobex</li>
<li>Raloxifene Hydrochloride</li>
<li>Sodium Picosulfate</li>
</ul>
</td>
</tr>

<tr>
<td><strong>Therapeutic / Chemical Segments</strong></td>
<td>
<ul>
<li>Antidiabetic</li>
<li>Ophthalmic</li>
<li>Muscle Relaxants</li>
<li>Antithrombotic</li>
<li>Antileprosy</li>
<li>Antiviral &amp; Immunomodulator</li>
<li>Diuretics</li>
<li>Anxiolytics &amp; Antidepressants</li>
<li>Oncology</li>
<li>Dermatology</li>
<li>Gastrointestinal</li>
<li>Diagnostic Agents</li>
<li>Antifibrotic Agents</li>
</ul>
</td>
</tr>

<tr>
<td><strong>CRDMO Services</strong></td>
<td>
<ul>
<li>Process Chemistry</li>
<li>Research &amp; Development</li>
<li>Analytical Development</li>
<li>Technology Transfer</li>
<li>Scale-Up</li>
<li>Commercial Manufacturing</li>
<li>Quality Assurance &amp; Quality Control</li>
<li>Regulatory Affairs</li>
<li>Supply Chain Management</li>
<li>Project Management</li>
<li>Intellectual Property Support</li>
</ul>
</td>
</tr>

<tr>
<td><strong>R&amp;D Facility</strong></td>
<td>40,000 sq. ft. R&amp;D Centre of Excellence</td>
</tr>

<tr>
<td><strong>R&amp;D Team</strong></td>
<td>100+ Scientists and PhDs</td>
</tr>

<tr>
<td><strong>Chemistry Expertise</strong></td>
<td>43+ Chemistry Types / Processes</td>
</tr>

<tr>
<td><strong>Manufacturing Facility</strong></td>
<td>7 Manufacturing Blocks comprising 5 API Blocks and 2 Intermediate Blocks</td>
</tr>

<tr>
<td><strong>Production Scale</strong></td>
<td>0.5 kg to 2 MT</td>
</tr>

<tr>
<td><strong>Manufacturing Capacity</strong></td>
<td>Up to 200 KL</td>
</tr>

<tr>
<td><strong>Quality Standards &amp; Accreditations</strong></td>
<td>USFDA, EU-GMP, PMDA, WHO-GMP, ISO 9001, ISO 14001, ISO 45001 and EcoVadis</td>
</tr>

<tr>
<td><strong>Quality Management</strong></td>
<td>cGMP, GLP, GDP, GSP and GEP-based quality systems with Quality by Design (QbD), process management, risk assessment and compliance systems</td>
</tr>

<tr>
<td><strong>Analytical Capabilities</strong></td>
<td>LCMS, GCMS, HPLC, UPLC, impurity profiling, method development, validation and stability studies</td>
</tr>

<tr>
<td><strong>Global Presence</strong></td>
<td>37+ Countries</td>
</tr>

<tr>
<td><strong>Employees</strong></td>
<td>To Be Confirmed</td>
</tr>

<tr>
<td><strong>Legal Status</strong></td>
<td>Private Limited Company</td>
</tr>

<tr>
<th colspan=”2″>Statutory Profile</th>
</tr>

<tr>
<td><strong>GST No.</strong></td>
<td>23AABCM1739L1ZI</td>
</tr>

<tr>
<td><strong>Import Export Status</strong></td>
<td>Exporter</td>
</tr>

<tr>
<td><strong>Import Export Code (IEC)</strong></td>
<td>To Be Confirmed</td>
</tr>

<tr>
<td><strong>PAN</strong></td>
<td>To Be Confirmed</td>
</tr>

<tr>
<th colspan=”2″>Packaging, Payment &amp; Shipment Details</th>
</tr>

<tr>
<td><strong>Packaging Facilities</strong></td>
<td>Central Packaging Area with product-specific packaging for APIs, pharmaceutical intermediates and specialty chemicals</td>
</tr>

<tr>
<td><strong>Payment Mode</strong></td>
<td>To Be Confirmed</td>
</tr>

<tr>
<td><strong>Shipment Mode</strong></td>
<td>To Be Confirmed</td>
</tr>

<tr>
<td><strong>Market Served</strong></td>
<td>India and International Markets</td>
</tr>

</tbody>
</table>
</div>